drugset / Trial / NCT02298023

Treatment of Tendon Injury Using Allogenic Adipose-derived Mesenchymal Stem Cells (Rotator Cuff Tear)

NCT02298023

Phase 2 Completed 24 enrolled Seoul National University Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Main purpose of this study is to evaluate efficacy of allogenic adipose-derived mesenchymal stem cells in treatment of tendon injury. ALLO-ASC will be administrated to the patients with supraspinatus partial thickness tear by ultrasonographic guided injection.

Timeline

Start
2014-09
Primary completion
2016-07-19
Completion
2018-04-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fibrinogen Concentrate Human Protein / enzyme biologic 0.5 ml Other
Subject allogenic adipose stem cell Cell therapy 0.5 ml Other
Subject allogenic adipose stem cell Cell therapy 1e+07 cells Other

Indications